The American Society of Clinical Oncology believes it is the right time to remind insurers and policymakers that utilization management tools be used in the right way.

As some U.S. senators work on overturning the ban on individuals importing prescription drugs, a Denver-based family therapist is watching developments in Congress with particular interest.

A recent close study of the Ebola virus, a disease the World Health Organization says is fatal in up to 50 percent of those infected, have may revealed clues vital for the development of new treatment methods.

The fight against two infectious diseases common in Africa received a boost from a $300,000 grant from pharmaceutical giant Merck & Co.

Gut bacteria could transform a nutrient in food into a blood clot-enhancing compound, according to a study in the American Heart Association's journal Circulation.

A drug currently under evaluation for patients suffering from multiple sclerosis showed positive results during a 16-month clinical trial, Novartis said in a release.

The American Heart Association and Macy’s have launched the second annual #GoRedGetFit online fitness challenge to encourage women to make lifestyle changes through quarterly health and fitness challenges.

Biotechnology company Shire recently shared its findings that the Global Annual Bleed Rate (GABR) showed a bleeding incident occurs every 3 to 15 seconds in hemophiliac patients worldwide.

The U.S. House could vote as early as this week on a revised health care bill following the filing of amendments designed to bridge the gap between different camps that led to an earlier version being pulled before a vote.

A posting on the American Cancer Society's website said the Food and Drug Administration has approved a new medication for adults undergoing treatment for acute myeloid leukemia (AML).

An amendment to the House Republican health care bill is an effort toward satisfying the wish list of conservatives, though many are still pushing for outright repeal of the Affordable Care Act.

The Food and Drug Administration has approved a drug that can be used to treat a rare pediatric brain disorder in children known as late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), a BioMarin Pharmaceutical Inc. release said.

The Food and Drug Administration has approved Horizon Pharma's supplemental new drug application to expand the use of Ravicti (glycerol henylbutyrate), an oral liquid used to treat urea cycle disorders (UCDs) in patients who are unable to manage the condition with dietary restriction or amino acid supplementation, to patients as young as 2 months old.

Johnson & Johnson Human Performance Institute (JJHPI) said it launched a new in-depth training solution for managing stress, Corporate Athlete Resilience, which uses a holistic, science-based approach to managing stress to increase productivity and build resilience.

Amendments to a Republican health care bill are "a good step forward in the conservative effort to repeal the Affordable Care Act," according to a health care policy expert.

To meet demand for its medication for adult patients that have active, autoantibody-positive, systemic lupus erthermatosus (SLE), GlaxoSmithKline (GSK) said it will put $139 million into its biopharmaceutical manufacturing location in Rockville, Maryland.

A survey conducted by Sanofi and Regeneron Pharmaceuticals Inc. found that approximately 80 percent of the 1,000 rheumatoid arthritis (RA) patients surveyed experienced life-altering levels of pain, a Genzyme release said.

Sanofi Genzyme said it presented six years of data on the use of Lemtrada (alemtuzumab) to treat patients with relapsing remitting multiple sclerosis (RRMS) at the 69th annual meeting of the American Academy of Neurology (AAN).

Sanofi Genzyme said data from the Phase III TOPIC study on the effects of Aubagio (teriflunomide) on cortical gray matter atrophy was presented at the 69th annual meeting of the American Academy of Neurology (AAN). The study evaluated Aubagio versus a placebo in patients with a first clinical episode suggestive of multiple sclerosis (MS).

A recent Health Affairs study suggests that primary care physicians spend 49% of their clinical time on face-to-face visits with patients and 51% on what study authors call “desktop medicine,” and payment policies should reflect that, according to the American Academy of Family Physicians, or AAFP.